Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
EGRX Eagle Pharmaceuticals, Inc. daily Stock Chart
EGRX [NASD]
Eagle Pharmaceuticals, Inc.
Healthcare | Drugs - Generic | USA
statements
Index- P/E33.69 EPS (ttm)1.78 Insider Own11.63% Shs Outstand13.48M Perf Week6.33%
Market Cap808.80M Forward P/E19.64 EPS next Y3.06 Insider Trans-4.81% Shs Float12.05M Perf Month2.74%
Income25.90M PEG30.63 EPS next Q0.49 Inst Own97.60% Short Float13.59% Perf Quarter2.11%
Sales203.70M P/S3.97 EPS this Y-40.00% Inst Trans-2.42% Short Ratio11.09 Perf Half Y13.38%
Book/sh12.86 P/B4.67 EPS next Y18.41% ROA10.20% Target Price57.00 Perf Year39.18%
Cash/sh8.69 P/C6.90 EPS next 5Y1.10% ROE15.10% 52W Range36.03 - 64.94 Perf YTD48.92%
Dividend- P/FCF8.37 EPS past 5Y37.60% ROI16.80% 52W High-7.61% Beta1.40
Dividend %- Quick Ratio4.10 Sales past 5Y73.20% Gross Margin66.70% 52W Low66.52% ATR2.10
Employees96 Current Ratio4.20 Sales Q/Q-19.90% Oper. Margin17.00% RSI (14)57.15 Volatility3.21% 3.42%
OptionableYes Debt/Eq0.23 EPS Q/Q-119.30% Profit Margin12.70% Rel Volume1.86 Prev Close59.14
ShortableYes LT Debt/Eq0.20 EarningsNov 12 BMO Payout0.00% Avg Volume147.64K Price60.00
Recom2.20 SMA205.59% SMA500.68% SMA2009.09% Volume274,593 Change1.45%
Nov-01-18Downgrade Cantor Fitzgerald Overweight → Neutral
Oct-31-18Downgrade Piper Jaffray Overweight → Neutral
Mar-21-18Reiterated Mizuho Underperform $37 → $40
Nov-09-17Reiterated RBC Capital Mkts Outperform $81 → $75
Sep-06-17Reiterated Mizuho Underperform $40 → $37
Jul-27-17Reiterated RBC Capital Mkts Outperform $94 → $81
Jul-27-17Reiterated Mizuho Underperform $57 → $40
May-09-17Reiterated RBC Capital Mkts Outperform $86 → $94
Jan-09-17Downgrade Mizuho Neutral → Underperform $78 → $64
Nov-16-16Downgrade Mizuho Buy → Neutral $78
Nov-03-16Upgrade Mizuho Neutral → Buy $62 → $78
Nov-03-16Reiterated RBC Capital Mkts Outperform $80 → $93
Oct-26-16Reiterated Mizuho Buy $65 → $62
Aug-16-16Reiterated Mizuho Neutral $47 → $65
Jun-20-16Downgrade Mizuho Buy → Neutral $66 → $47
May-10-16Reiterated RBC Capital Mkts Outperform $94 → $78
Mar-18-16Reiterated Mizuho Buy $81 → $71
Feb-26-16Reiterated Mizuho Buy $112 → $81
Dec-09-15Initiated Mizuho Buy $112
Jul-29-15Reiterated Piper Jaffray Overweight $94 → $119
Dec-13-19 02:53PM  Eagle Pharmaceuticals Reaches Settlement Agreement with Eli Lilly for PEMFEXY (pemetrexed for injection) Business Wire
Dec-11-19 11:25AM  Eagle Pharmaceuticals Inc (EGRX): Are Hedge Funds Right About This Stock? Insider Monkey
Dec-09-19 06:50AM  Eagle Pharmaceuticals Commences Dosing in Pilot Study for Novel Estrogen Receptor Antagonist Product Candidate Business Wire
Dec-03-19 08:45AM  If You Had Bought Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Five Years Ago, You Could Pocket A 336% Gain Today Simply Wall St.
Nov-21-19 07:49AM  Edited Transcript of EGRX earnings conference call or presentation 12-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-20-19 06:50AM  Eagle Pharmaceuticals to Present at 31st Annual Piper Jaffray Healthcare Conference Business Wire
Nov-14-19 06:50AM  Eagle Pharmaceuticals Announces Departure of Douglas L. Braunstein from Board of Directors Business Wire
Nov-12-19 08:15AM  Eagle Pharmaceuticals (EGRX) Q3 Earnings and Revenues Lag Estimates Zacks -5.61%
06:51AM  Eagle Pharmaceuticals Reports Third Quarter 2019 Results Business Wire
06:50AM  Eagle Pharmaceuticals Announces Enrollment of Additional Exertional Heat Stroke Patients at the 2019 Hajj Pilgrimage Business Wire
Nov-09-19 02:26PM  Do Hedge Funds Love Eagle Pharmaceuticals Inc (EGRX)? Insider Monkey
Nov-05-19 10:31AM  Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-31-19 04:30PM  Eagle Pharmaceuticals to Discuss Third Quarter 2019 Financial Results on November 12, 2019 Business Wire
10:34AM  Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-28-19 08:02AM  An Intrinsic Calculation For Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Suggests It's 39% Undervalued Simply Wall St.
Oct-17-19 09:28AM  New Strong Sell Stocks for October 17th Zacks
Oct-07-19 06:50AM  Eagle Pharmaceuticals Japanese Licensing Partner SymBio Announces its Submission of a New Drug Application for TREAKISYM® Ready-To-Dilute Formulation Business Wire
Oct-02-19 02:39PM  Here's What Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) P/E Is Telling Us Simply Wall St.
Sep-24-19 11:30AM  Zacks.com featured highlights include: Garmin, Eagle Pharmaceuticals, BMC Stock, SeaWorld and Zumiez Zacks
Sep-23-19 04:30PM  Eagle Pharmaceuticals, Inc. to Present at 2019 Cantor Global Healthcare Conference Business Wire
08:32AM  5 Momentum Picks Screened on Driehaus Strategy Zacks
Sep-10-19 07:29AM  Does The Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Share Price Tend To Follow The Market? Simply Wall St.
Sep-04-19 08:40AM  Insulet (PODD) Catches Eye: Stock Jumps 8.9% Zacks
Aug-30-19 01:49PM  Edited Transcript of EGRX earnings conference call or presentation 8-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-28-19 04:30PM  Eagle Pharmaceuticals, Inc. to Present at Morgan Stanley 17th Annual Global Healthcare Conference Business Wire
Aug-20-19 04:47PM  Nabriva (NBRV) Gains FDA Approval for Pneumonia Drug Xenleta Zacks
Aug-18-19 10:21AM  Should Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Be Your Next Stock Pick? Simply Wall St.
Aug-14-19 10:29AM  New Strong Buy Stocks for August 14th Zacks
Aug-09-19 06:23AM  Eagle Pharmaceuticals Inc (EGRX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-08-19 08:45AM  Eagle Pharmaceuticals (EGRX) Beats Q2 Earnings and Revenue Estimates Zacks
06:50AM  Eagle Pharmaceuticals, Inc. Reports Second Quarter 2019 Results Business Wire
Aug-05-19 06:50AM  Eagle Pharmaceuticals Announces Clinical Development Plan of Innovative Product Intended to Deliver Maximum Estrogen Receptor Inhibition in Patients with Estrogen Receptor (ER)-Positive Breast Cancer Business Wire
Aug-01-19 10:33AM  Earnings Preview: Eagle Pharmaceuticals (EGRX) Q2 Earnings Expected to Decline Zacks
Jul-29-19 04:30PM  Eagle Pharmaceuticals to Discuss Second Quarter 2019 Financial Results on August 8, 2019 Business Wire
Jul-26-19 07:54AM  Is Eagle Pharmaceuticals (NASDAQ:EGRX) Using Too Much Debt? Simply Wall St.
Jul-03-19 01:59PM  Should You Worry About Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) CEO Pay Cheque? Simply Wall St.
08:48AM  Park Service diverts $2.5 million in fees to pay for Trumps July 4th celebration | Beto ORourke says hes unaware of his fundraising numbers MarketWatch
May-31-19 03:07PM  Here's Why I Think Eagle Pharmaceuticals (NASDAQ:EGRX) Might Deserve Your Attention Today Simply Wall St.
May-28-19 04:30PM  Eagle Pharmaceuticals, Inc. to Present at Jefferies 2019 Global Healthcare Conference Business Wire
May-15-19 06:34PM  Edited Transcript of EGRX earnings conference call or presentation 7-May-19 12:30pm GMT Thomson Reuters StreetEvents
04:30PM  Eagle Pharmaceuticals, Inc. to Present at 2019 RBC Capital Markets Global Healthcare Conference Business Wire
May-09-19 08:43PM  Hedge Funds Have Never Been More Bullish On Eagle Pharmaceuticals Inc (EGRX) Insider Monkey
May-08-19 06:00AM  Can Eagle Pharma Fly through its Oncology Trials MoneyShow
May-07-19 12:23PM  Eagle Pharmaceuticals Inc (EGRX) Q1 2019 Earnings Call Transcript Motley Fool +6.89%
08:05AM  Eagle Pharmaceuticals (EGRX) Beats Q1 Earnings and Revenue Estimates Zacks
07:04AM  Did You Miss Eagle Pharmaceuticals's (NASDAQ:EGRX) Whopping 457% Share Price Gain? Simply Wall St.
06:58AM  Eagle Pharmaceuticals: 1Q Earnings Snapshot Associated Press
06:50AM  Eagle Pharmaceuticals, Inc. Reports First Quarter 2019 Results Business Wire
06:45AM  Eagle Pharmaceuticals Announces Positive Results of a Study Conducted in Partnership with the U.S. Military to Evaluate Neuroprotective Effects of RYANODEX for the Treatment of Nerve Agent Exposure Business Wire
Apr-30-19 10:32AM  Eagle Pharmaceuticals (EGRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-29-19 06:50AM  Eagle Pharmaceuticals to Discuss First Quarter 2019 Financial Results on May 7, 2019 Business Wire
Apr-22-19 09:48AM  New Strong Sell Stocks for April 22nd Zacks
06:50AM  CMS Establishes Unique J-Code for BELRAPZO (Bendamustine 500mL Hydrochloride Injection) Business Wire
Apr-15-19 06:50AM  Eagle Pharmaceuticals, Inc. Expands Licensing Agreement for BENDEKA with Teva Pharmaceuticals International GmbH Business Wire
Apr-03-19 02:09PM  Don't Sell Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Before You Read This Simply Wall St.
Mar-28-19 07:35AM  Consolidated Research: 2019 Summary Expectations for Penn National Gaming, Nomad Foods, Americold Realty Trust, Cboe Global Markets, Eagle Pharmaceuticals, and National Commerce Fundamental Analysis, Key Performance Indications GlobeNewswire
Mar-07-19 12:02AM  Edited Transcript of EGRX earnings conference call or presentation 28-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 02:44PM  Eagle Pharmaceuticals Inc (EGRX) Q4 2018 Earnings Conference Call Transcript Motley Fool
06:50AM  Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2018 Results Business Wire
06:30AM  Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-19 11:06AM  Is Eagle Pharmaceuticals, Inc.s (NASDAQ:EGRX) ROE Of 15% Impressive? Simply Wall St.
10:31AM  Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-19-19 04:30PM  Eagle Pharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019 Business Wire
Feb-18-19 10:30AM  Earnings Preview: Eagle Pharmaceuticals (EGRX) Q4 Earnings Expected to Decline Zacks
Feb-14-19 09:10AM  Should Value Investors Buy Eagle Pharmaceuticals (EGRX) Stock? Zacks
Jan-04-19 06:51AM  Does Eagle Pharmaceuticals, Inc.s (NASDAQ:EGRX) CEO Pay Matter? Simply Wall St. +5.67%
Jan-02-19 07:00AM  Eagle Pharmaceuticals, Inc. to Present at 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-16-18 10:49PM  Hedge Funds Are Selling Eagle Pharmaceuticals Inc (EGRX) Insider Monkey
Nov-30-18 07:45AM  Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-27-18 06:50AM  Eagle Pharmaceuticals Announces Positive Results of Pre-clinical Study Conducted to Evaluate Effects of RYANODEX in Acute Radiation Syndrome (ARS) Business Wire
Nov-26-18 09:05AM  Investors Are Undervaluing Eagle Pharmaceuticals Inc (NASDAQ:EGRX) By 28.8% Simply Wall St.
Nov-19-18 07:00AM  Eagle Pharmaceuticals, Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-16-18 04:32AM  Moving Average Crossover Alert: Eagle Pharmaceuticals (EGRX) Zacks
Nov-07-18 11:10AM  Edited Transcript of EGRX earnings conference call or presentation 1-Nov-18 12:30pm GMT Thomson Reuters StreetEvents
Nov-01-18 10:41AM  Eagle Pharmaceuticals (EGRX) Q3 Earnings Match Estimates Zacks +6.07%
08:21AM  Eagle Pharmaceuticals: 3Q Earnings Snapshot Associated Press
06:50AM  Eagle Pharmaceuticals, Inc. Reports Third Quarter 2018 Results Business Wire
Oct-30-18 06:50AM  Eagle Pharmaceuticals Commences $50 Million Accelerated Share Repurchase as Part of New $150 Million Share Repurchase Authorization Business Wire -16.52%
06:45AM  Eagle Pharmaceuticals Announces Results of Study for Fulvestrant Business Wire
Oct-25-18 05:00PM  Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2018 Financial Results on November 1, 2018 Business Wire
Oct-23-18 07:25AM  Market Trends Toward New Normal in IAC/InterActiveCorp, Eagle Pharmaceuticals, Arrowhead Pharmaceuticals, The Manitowoc, Brookdale Senior Living, and LATAM Airlines Group S.A Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-19-18 09:28AM  Is Eagle Pharmaceuticals Inc (NASDAQ:EGRX) Attractive At Its Current PE Ratio? Simply Wall St.
Oct-03-18 07:00AM  Eagle Pharmaceuticals Enters into Agreement with USAMRICD to Evaluate Neuroprotective Effects of RYANODEX Secondary to Nerve Agent Exposure Business Wire
Sep-27-18 07:00AM  Eagle Pharmaceuticals, Inc. To Present At Cantor Global Healthcare Conference Business Wire
Sep-26-18 04:30PM  Eagle Appoints David Pernock to Position of Chief Operating Officer Business Wire
Sep-11-18 10:41AM  Does Eagle Pharmaceuticals Inc (NASDAQ:EGRX) Fall With The Market? Simply Wall St.
Sep-07-18 08:32AM  Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod Zacks
Sep-05-18 10:21AM  Agios (AGIO) Assigns Ex-Celgene Executive to CEO Position Zacks
Sep-04-18 04:30PM  Eagle Pharmaceuticals, Inc. to Present at Morgan Stanley 16th Annual Global Healthcare Conference Business Wire
Aug-30-18 07:00AM  Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate RYANODEX for Exertional Heat Stroke Business Wire -16.28%
Aug-28-18 07:30AM  Analysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-23-18 07:00AM  Eagle Pharmaceuticals Named to Fortune 100 List of Fastest-Growing Companies Business Wire
Aug-22-18 09:02AM  Eagle Pharmaceuticals Announces New Patent Issued for BENDEKA Business Wire
Aug-20-18 03:34PM  Edited Transcript of EGRX earnings conference call or presentation 7-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 08:15AM  Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Top Estimates Zacks
07:09AM  Eagle Pharmaceuticals: 2Q Earnings Snapshot Associated Press
06:50AM  Eagle Pharmaceuticals, Inc. Reports Second Quarter 2018 Results Business Wire
06:30AM  Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 11:21AM  Emergent (EBS) Q2 Earnings and Revenues Surpass Estimates Zacks
Aug-02-18 11:47AM  Conatus' (CNAT) Q2 Loss Narrows, Revenues Lag Marginally Zacks
Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers Argatroban, an anti-coagulant thrombin inhibitor for heparin-induced thrombocytopenia; Ryanodex for malignant hyperthermia; Bendeka for chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma (NHL); and Belrapzo, a chemotherapeutic agent for CLL and Indolent NHL. Its product candidates also includes EP-4104, a dantrolene sodium for exertional heat stroke; EP-5101 (PEMFEXY) for lung cancer and mesothelioma; EGL-5385-C-1701 (fulvestrant) for breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. Eagle Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hudson Executive Capital LPDirectorOct 25Sale63.5715,437981,302732,777Oct 28 04:40 PM
Hudson Executive Capital LPDirectorOct 24Sale62.531,49493,412748,214Oct 28 04:40 PM
Hudson Executive Capital LPDirectorOct 23Sale62.5820012,516749,708Oct 23 06:58 PM
Hudson Executive Capital LPDirectorOct 22Sale62.686,567411,618749,908Oct 23 06:58 PM
Hudson Executive Capital LPDirectorOct 21Sale62.563,849240,791756,475Oct 23 06:58 PM
Hudson Executive Capital LPDirectorOct 18Sale62.611,600100,174760,324Oct 18 05:29 PM
Hudson Executive Capital LPDirectorOct 17Sale62.5813,842866,196761,924Oct 18 05:29 PM
Hudson Executive Capital LPDirectorOct 16Sale62.501026,375775,766Oct 18 05:29 PM
Hudson Executive Capital LPDirectorOct 15Sale62.633,909244,836775,868Oct 15 06:24 PM
Hudson Executive Capital LPDirectorOct 11Sale60.3916,300984,419779,777Oct 15 06:24 PM
Hudson Executive Capital LPDirectorOct 10Sale60.167,829471,002796,077Oct 15 06:24 PM
Hudson Executive Capital LPDirectorOct 08Sale60.031,55893,520803,906Oct 09 04:13 PM
Hudson Executive Capital LPDirectorOct 07Sale60.114,901294,600805,464Oct 09 04:13 PM
Hudson Executive Capital LPDirectorSep 17Sale60.001006,000810,365Sep 19 04:13 PM
Hudson Executive Capital LPDirectorSep 12Sale60.0720012,014810,465Sep 13 04:43 PM
Hudson Executive Capital LPDirectorSep 11Sale60.061,11266,785810,665Sep 13 04:43 PM
Braunstein Douglas LDirectorMay 10Sale56.14100,0005,614,000811,777May 13 05:52 PM
Braunstein Douglas LDirectorMay 09Sale57.9559,2233,431,973911,777May 13 05:52 PM
Tarriff ScottCEOApr 01Sale50.1524,9751,252,4961,500,202Apr 03 04:33 PM
FLAUM SANDER ADirectorMar 05Option Exercise4.042,3409,45413,714Mar 06 04:41 PM
RATOFF STEVEN BDirectorMar 04Option Exercise4.042,3409,45418,004Mar 06 04:42 PM
Tarriff ScottCEOMar 01Sale51.1724,4281,250,0151,525,177Mar 04 04:31 PM
Tarriff ScottCEOJan 03Sale39.2916,569651,0581,518,390Jan 04 09:22 PM
Tarriff ScottCEOJan 02Sale39.7115,000595,7051,534,959Jan 04 09:22 PM
open in yahoo | open in reuters | open in google